Concourse Financial Group Securities, Inc. Night Hawk Biosciences, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share
Q1 2024 Apr 30, 2024	BUY	$0.15 - $0.45 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.26 - $0.51 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.5 - $0.72 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.5 - $0.72 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.62 - $0.87 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.83 - $1.24 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.77 - $1.62 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.79 - $2.96 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.65 - $3.13 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.1 - $3.54 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.04 - $6.01 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$5.9 - $7.44 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$5.78 - $9.6 $0 - $0
Q1 2021 May 13, 2021	BUY	$5.67 - $12.54 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$5.28 - $9.59 $0 - $0

Others Institutions Holding NHWK

# of Institutions

Shares Held

48.5K

Call Options Held

Put Options Held

View Full List

About NightHawk Biosciences, Inc.

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

More about NHWK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account